Patent · US Active

Telodendrimers and nanocarriers and methods of using same

US11406714B2 · kind B2 · utility

0Cited by
1References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 21, 2013
Grant dateAug 9, 2022
Priority date
Expiry dateFeb 6, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K49/0054
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are functional segregated telodendrimers having, for example, two or three functional segments. The telodendrimers can have one or more crosslinking groups (e.g., reversible photocrosslinking groups). The telodendrimers can aggregate to form nanocarriers. Cargo such as drugs, imaging probes, and other materials may be sequestered in the core of the aggregates via non-covalent or covalent interactions with the telodendrimers. Such nanocarriers may be used in drug delivery applications and imaging applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.